Last updated: 17 May 2022 at 7:04pm EST

Mehrezad Khakpour Net Worth




The estimated Net Worth of Mehrezad Khakpour is at least $20.9 Тысяча dollars as of 13 May 2022. Mehrezad Khakpour owns over 2,424 units of Sonendo stock worth over $14,143 and over the last 3 years Mehrezad sold SONX stock worth over $6,739.

Mehrezad Khakpour SONX stock SEC Form 4 insiders trading

Mehrezad has made over 1 trades of the Sonendo stock since 2022, according to the Form 4 filled with the SEC. Most recently Mehrezad sold 2,424 units of SONX stock worth $6,739 on 13 May 2022.

The largest trade Mehrezad's ever made was selling 2,424 units of Sonendo stock on 13 May 2022 worth over $6,739. On average, Mehrezad trades about 808 units every 0 days since 2021. As of 13 May 2022 Mehrezad still owns at least 235,720 units of Sonendo stock.

You can see the complete history of Mehrezad Khakpour stock trades at the bottom of the page.



What's Mehrezad Khakpour's mailing address?

Mehrezad's mailing address filed with the SEC is C/O SONENDO, INC., 26061 MERIT CIRCLE, SUITE 102, LAGUNA HILLS, CA, 92653.

Insiders trading at Sonendo

Over the last 3 years, insiders at Sonendo have traded over $1,077,789 worth of Sonendo stock and bought 3,564,237 units worth $2,011,760 . The most active insiders traders include Vamsi Mohan Raj Pudipeddi, Olav Bergheim и Atlantic, L.P.General Atlan.... On average, Sonendo executives and independent directors trade stock every 9 days with the average trade being worth of $2,679. The most recent stock trade was executed by Bjarne Bergheim on 21 June 2024, trading 43,240 units of SONX stock currently worth $3,892.



What does Sonendo do?



What does Sonendo's logo look like?

Sonendo, Inc. logo

Complete history of Mehrezad Khakpour stock trades at Sonendo

Дата
#
Компания
инсайдер
Транзакция
Транзакция
Акции Цена за акцию Общая стоимость Акции после Источник
13 May 2022 Mehrezad Khakpour
Главный технический директор
Продажа 2,424 $2.78 $6,739
13 May 2022
235,720


Sonendo executives and stock owners

Sonendo executives and other stock owners filed with the SEC include: